Search Login Register

ONO 3708 Summary

21 relevant articles (2 outcomes, 2 trials/studies) found for this Bio-Agent

Description: structure given in first source; thromboxane A2 antagonist

Also Known As: (9,11)(11,12)-dideoxa-9 alpha,11 alpha-dimethylmethano-11,12-methano-13,14-dihydro-13-aza-14-oxo-15-cyclopentyl-16,17,18,19,20-pentanor-15-epi-TXA2; (9,11),(11,12)-dideoxa-9,11-dimethylmethano-11,12-methano-13,14-dihydro-13-azo-14-oxo-15-cyclopentyl-16,17,18,19,20-pentanor-15-epithromboxane A2; ONO-3708; 5-Heptenoic acid, 7-(3-((cyclopentylhydroxyacetyl)amino)-6,6-dimethylbicyclo(3.1.1)hept-2-yl)-, (1S-(1alpha,2beta(Z),3alpha(S*),5alpha))-

Key Diseases for which ONO 3708 is Relevant

  1. Shock : 1 outcome in 2 results
  2. Thrombocytopenia (Thrombopenia) : 1 outcome in 1 result
  3. Necrosis : 1 outcome in 1 result
  4. Leukopenia : 1 outcome in 1 result
  5. Ischemia : 1 study in 4 results
Show All >>

Drugs Related to ONO 3708

  1. Prostaglandin H2 Thromboxane A2 Receptors
  2. ozagrel
  3. Transaminases
  4. Thromboxane Receptors (Thromboxane Receptor)
  5. Thromboxane A2 (A2, Thromboxane)
  6. Epoprostenol (Prostacyclin)
  7. Indomethacin (Indometacin)
  8. prostaglandin endoperoxide receptor
  9. Oleic Acid (Oleate)
  10. Thromboxane-A Synthase
Show All >>

Therapies Related to ONO 3708


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.